Authors: Tornatore, KM Garey, KW Saigal, N Reed, K Murray, B Ingalls, E DiFrancesco, R Forrest, A Morse, G Venuto, R

Citation: Km. Tornatore et al., Ganciclovir pharmacokinetics and cytokine dynamics in renal transplant recipients with cytomegalovirus infection, CLIN TRANSP, 15(5), 2001, pp. 297-308

Authors: Friedland, GH Pollard, R Griffith, B Hughes, M Morse, G Bassett, R Freimuth, W Demeter, L Connick, E Nevin, T Hirsch, M Fischl, M

Citation: Gh. Friedland et al., Efficacy and safety of delavirdine mesylate with zidovudine and didanosinecompared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm(3) (ACTG 261), J ACQ IMM D, 21(4), 1999, pp. 281-292

Authors: Para, MF Meehan, P Holden-Wiltse, J Fischl, M Morse, G Shafer, R Demeter, LM Wood, K Nevin, T Virani-Ketter, N Freimuth, WW

Citation: Mf. Para et al., ACTG 260: a randomized, phase I-II, dose-ranging trial of the anti-human immunodeficiency virus activity of delavirdine monotherapy, ANTIM AG CH, 43(6), 1999, pp. 1373-1378